Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection

Preclinical In Vitro and In Vivo Characterization of the Fully Human Monoclonal IgM Antibody KBPA101 Specific for Pseudomonas aeruginosa Serotype IATS-O11

(2010) M. P. Horn et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics and Safety Profile of the Human Anti-Pseudomonas aeruginosa Serotype O11 Immunoglobulin M Monoclonal Antibody KBPA-101 in Healthy Volunteers

(2009) H. Lazar et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Update on the treatment of Pseudomonas aeruginosa pneumonia

(2009) A. A. El Solh et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Anti-Inflammatory and Proresolving Mediator Resolvin E1 Protects Mice from Bacterial Pneumonia and Acute Lung Injury

(2009) H. Seki et al.   JOURNAL OF IMMUNOLOGY

Effect of IL-10 on Neutrophil Recruitment and Survival afterPseudomonas aeruginosaChallenge

(2008) Lei Sun et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis

(2008) Victoria L. Campodónico et al.   TRENDS IN MOLECULAR MEDICINE